Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
Background: There is underutilization of long-acting injectable (LAI) antipsychotics for first-episode schizophrenia (FES) despite having convenient dosing and treatment retention. LAIs are predominantly used for patients with poor compliance, chronic course, and multiple relapses. Materials and Met...
Saved in:
Main Authors: | Ramandeep Kaur, Ajeet Sidana, Nidhi Malhotra, Shikha Tyagi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-04-01
|
Series: | Indian Journal of Psychiatry |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/indianjpsychiatry.indianjpsychiatry_389_22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01) -
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
by: Miquel Bernardo, et al.
Published: (2025-01-01) -
Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders
by: Bole Cvetka Bačar, et al.
Published: (2017-03-01) -
Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report
by: Xiaobo Xie, et al.
Published: (2025-01-01) -
Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01)